LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Deciphera Pharmaceuticals (NASDAQ: DCPH)

Follow NASDAQ:DCPH Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ DCPH Deciphera Pharmaceuticals
Brightstar Associates LLC / 10 percent owner
04/22/2024
Buy
$0.01
48,136
$481
23.11M
NASDAQ DCPH Deciphera Pharmaceuticals
Brightstar Associates LLC / 10 percent owner
04/22/2024
Sell
$0.01
48,136
$481
0
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
02/16/2024
Sell
$15.62
2,615
$41K
108,739
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
02/15/2024
Buy
$15.92
69,100
$1.100M
69,100
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
02/16/2024
Sell
$15.62
3,010
$47K
80,350
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
02/15/2024
Buy
$15.92
69,100
$1.100M
69,100
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: SVP, Chief Development Officer
02/16/2024
Sell
$15.62
2,267
$35K
68,031
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: SVP, Chief Development Officer
02/15/2024
Buy
$15.92
38,900
$619K
38,900
NASDAQ DCPH Deciphera Pharmaceuticals
Hoerter Steven L. / director, officer: President and CEO
02/15/2024
Buy
$15.92
298,100
$4.746M
298,100
NASDAQ DCPH Deciphera Pharmaceuticals
Dhanak Dashyant / officer: EVP & Chief Scientific Officer
02/15/2024
Buy
$15.92
69,100
$1.100M
69,100
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
02/16/2024
Sell
$15.62
2,267
$35K
55,118
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
02/15/2024
Buy
$15.92
38,900
$619K
38,900
NASDAQ DCPH Deciphera Pharmaceuticals
Brightstar Associates LLC / 10 percent owner
02/07/2024
Buy
$0.01
914,001
$9K
23.06M
NASDAQ DCPH Deciphera Pharmaceuticals
Brightstar Associates LLC / 10 percent owner
02/07/2024
Sell
$0.01
914,001
$9K
48,136
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
01/16/2024
Sell
$14.47
2,435
$35K
94,079
NASDAQ DCPH Deciphera Pharmaceuticals
Walsh Dennis Leo / director
01/16/2024
Buy
$14.46
4,727
$68K
4,727
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: SVP, Chief Development Officer
01/16/2024
Sell
$14.47
1,624
$23K
50,573
NASDAQ DCPH Deciphera Pharmaceuticals
Friedman Franklin Stuart / director
01/16/2024
Buy
$14.46
4,727
$68K
4,727
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
01/16/2024
Sell
$14.47
2,435
$35K
66,085
NASDAQ DCPH Deciphera Pharmaceuticals
Allen Patricia L / director
01/16/2024
Buy
$14.46
4,727
$68K
4,727
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
01/16/2024
Sell
$14.47
1,624
$23K
47,660
NASDAQ DCPH Deciphera Pharmaceuticals
Squarer Ron / director
01/16/2024
Buy
$14.46
4,727
$68K
4,727
NASDAQ DCPH Deciphera Pharmaceuticals
Hoerter Steven L. / director, officer: President and CEO
12/13/2023
Sell
$15.37
30,664
$471K
72,763
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
12/13/2023
Sell
$15.37
2,792
$43K
68,520
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: See Remarks
12/13/2023
Sell
$15.37
1,662
$26K
52,197
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
12/13/2023
Sell
$15.37
1,727
$27K
49,284
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
12/13/2023
Sell
$15.37
2,792
$43K
96,514
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
11/30/2023
Sell
$12.57
17,801
$224K
45,435
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
10/30/2023
Sell
$12.02
2,360
$28K
90,628
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: See Remarks
10/30/2023
Sell
$12.02
1,407
$17K
48,283
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
10/30/2023
Sell
$12.02
1,407
$17K
62,884
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
10/30/2023
Sell
$12.02
2,316
$28K
63,068
NASDAQ DCPH Deciphera Pharmaceuticals
Hoerter Steven L. / director, officer: President and CEO
10/30/2023
Sell
$12.02
21,573
$259K
40,927
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
10/02/2023
Sell
$12.68
2,942
$37K
84,744
NASDAQ DCPH Deciphera Pharmaceuticals
Dhanak Dashyant / officer: EVP & Chief Scientific Officer
09/15/2023
Buy
$13.42
65,900
$884K
65,900
NASDAQ DCPH Deciphera Pharmaceuticals
Martin John Richard / director
06/21/2023
Buy
$14.91
30,000
$447K
30,000
NASDAQ DCPH Deciphera Pharmaceuticals
Benz Edward J. JR / director
06/21/2023
Buy
$14.91
30,000
$447K
30,000
NASDAQ DCPH Deciphera Pharmaceuticals
Bristol James Arthur / director
06/21/2023
Buy
$14.91
30,000
$447K
30,000
NASDAQ DCPH Deciphera Pharmaceuticals
Friedman Franklin Stuart / director
06/21/2023
Buy
$14.91
30,000
$447K
30,000
NASDAQ DCPH Deciphera Pharmaceuticals
Walsh Dennis Leo / director
06/21/2023
Buy
$14.91
30,000
$447K
30,000
NASDAQ DCPH Deciphera Pharmaceuticals
Kelley Susan L. / director
06/21/2023
Buy
$14.91
30,000
$447K
30,000
NASDAQ DCPH Deciphera Pharmaceuticals
Squarer Ron / director
06/21/2023
Buy
$14.91
30,000
$447K
30,000
NASDAQ DCPH Deciphera Pharmaceuticals
Allen Patricia L / director
06/21/2023
Buy
$14.91
30,000
$447K
30,000
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: See Remarks
06/16/2023
Sell
$14.40
1,238
$18K
43,812
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
06/16/2023
Sell
$14.40
1,655
$24K
87,686
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
06/16/2023
Sell
$14.40
1,655
$24K
57,140
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
06/16/2023
Sell
$14.40
1,238
$18K
58,413
NASDAQ DCPH Deciphera Pharmaceuticals
Flynn Daniel Lee / officer: Chief Scientific Officer
06/16/2023
Sell
$14.40
1,655
$24K
57,158
NASDAQ DCPH Deciphera Pharmaceuticals
Friedman Franklin Stuart / director
06/08/2023
Buy
$13.88
10,000
$139K
10,000
NASDAQ DCPH Deciphera Pharmaceuticals
Walsh Dennis Leo / director
05/10/2023
Buy
$13.86
11,000
$152K
11,000
NASDAQ DCPH Deciphera Pharmaceuticals
Hoerter Steven L. / director, officer: President and CEO
03/21/2023
Sell
$15.57
7,500
$117K
0
NASDAQ DCPH Deciphera Pharmaceuticals
Brightstar Associates LLC / 10 percent owner
02/28/2023
Buy
$0.01
2.43M
$24K
22.15M
NASDAQ DCPH Deciphera Pharmaceuticals
Brightstar Associates LLC / 10 percent owner
02/28/2023
Sell
$0.01
2.43M
$24K
962,137
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: See Remarks
02/16/2023
Sell
$15.10
1,159
$18K
45,050
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: See Remarks
02/15/2023
Buy
$15.48
44,600
$690K
44,600
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
02/16/2023
Sell
$15.10
1,159
$18K
58,381
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
02/15/2023
Buy
$15.48
44,600
$690K
44,600
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
02/15/2023
Buy
$15.48
65,900
$1.020M
65,900
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
02/16/2023
Sell
$15.10
1,370
$21K
58,795
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
02/16/2023
Sell
$15.10
971
$15K
88,145
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
02/15/2023
Buy
$15.48
65,900
$1.020M
65,900
NASDAQ DCPH Deciphera Pharmaceuticals
Flynn Daniel Lee / officer: Chief Scientific Officer
02/15/2023
Buy
$15.48
65,900
$1.020M
65,900
NASDAQ DCPH Deciphera Pharmaceuticals
Flynn Daniel Lee / officer: Chief Scientific Officer
02/16/2023
Sell
$15.10
1,370
$21K
58,813
NASDAQ DCPH Deciphera Pharmaceuticals
Hoerter Steven L. / director, officer: President and CEO
02/15/2023
Buy
$15.48
250,000
$3.870M
250,000
NASDAQ DCPH Deciphera Pharmaceuticals
Hoerter Steven L. / director, officer: President and CEO
02/14/2023
Sell
$16.00
30,045
$481K
7,500
NASDAQ DCPH Deciphera Pharmaceuticals
Brightstar Associates LLC / director
01/24/2023
Buy
$18.00
1.67M
$30.000M
19.72M
NASDAQ DCPH Deciphera Pharmaceuticals
Friedman Franklin Stuart / director
01/17/2023
Buy
$15.30
3,269
$50K
3,269
NASDAQ DCPH Deciphera Pharmaceuticals
Flynn Daniel Lee / officer: Chief Scientific Officer
01/17/2023
Sell
$21.24
2,403
$51K
43,695
NASDAQ DCPH Deciphera Pharmaceuticals
Pitman Jama / officer: See Remarks
01/17/2023
Sell
$21.24
1,603
$34K
35,058
NASDAQ DCPH Deciphera Pharmaceuticals
Sherman Matthew L / officer: EVP & Chief Medical Officer
01/17/2023
Sell
$21.24
2,403
$51K
72,628
NASDAQ DCPH Deciphera Pharmaceuticals
Allen Patricia L / director
01/17/2023
Buy
$15.30
3,269
$50K
3,269
NASDAQ DCPH Deciphera Pharmaceuticals
Martin Daniel C. / officer: Chief Commercial Officer
01/17/2023
Sell
$21.24
1,603
$34K
48,389
NASDAQ DCPH Deciphera Pharmaceuticals
Kelly Thomas Patrick / officer: Chief Financial Officer
01/17/2023
Sell
$21.24
2,403
$51K
43,677
NASDAQ DCPH Deciphera Pharmaceuticals
Walsh Dennis Leo / director
01/17/2023
Buy
$15.30
3,269
$50K
3,269
NASDAQ DCPH Deciphera Pharmaceuticals
Squarer Ron / director
01/17/2023
Buy
$15.30
3,269
$50K
3,269
NASDAQ DCPH Deciphera Pharmaceuticals
Kelley Susan L. / director
01/17/2023
Buy
$15.30
3,269
$50K
3,269

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous